The Trump administration has capped indirect costs for National Institutes of Health research grants at 15%. That would wipe ...
Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...